An American non-profit comprised of medical professionals has published a comprehensive resource online to separate fact from fiction on the subject of ketamine.
On Thursday, the American Society of Physicians, Psychotherapists, and Practitioners (ASKP3) announced the publication of its Patient Portal, a platform providing information on everything from research on ketamine to what the drug is and where to look for a clinic.
The organization says the wide range of information about the psychedelic from a variety of publications can be quite confusing for the public and it aims to clarify any misconceptions people have through hard factual data.
Read more: Choose Ketamine now offering at-home treatments in several states
Read more: Silo Pharma prepares pre-IND package for FDA on novel ketamine formulation
ASKP3 also says the Patient Portal was created through consulting with patient advocates and medical providers in conjunction with contemporary research collected by the organization’s ketamine specialists.
Additional content in the portal will include information on how ketamine is being utilized to treat pain and mood disorders, what to expect from therapy sessions involving the drug and what patients should be aware of if they are trying to determine whether ketamine treatments are a good fit for them.
The organization plans to add to the site as research on the subject of ketamine progresses with the intention of bringing the medical community together and empowering patients to find the most beneficial care for their specific needs.
“There is a lot of confusing information on the internet about ketamine. I am excited that ASKP3’s Patient Portal will provide a foundation for both patients and the broader medical community regarding ketamine as a treatment option, focused on neutral, fact-based science, to help patients make informed decisions about their healthcare,” said Sandhya Prashad, president of the ASKP3 and medical director at Houston Ketamine Therapeutics.
The non-profit has over 500 active members around the globe.
